Total Payments
$328,400
2024 Payments
$72,717
Companies
28
Transactions
452
Medicare Patients
4,079
Medicare Billing
$312,002
Payment Breakdown by Category
Other$273,377 (83.2%)
Consulting$26,594 (8.1%)
Travel$16,508 (5.0%)
Food & Beverage$8,413 (2.6%)
Research$3,500 (1.1%)
Education$7.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $253,677 | 136 | 77.2% |
| Consulting Fee | $26,594 | 19 | 8.1% |
| Honoraria | $19,700 | 6 | 6.0% |
| Travel and Lodging | $16,508 | 78 | 5.0% |
| Food and Beverage | $8,413 | 207 | 2.6% |
| Unspecified | $3,500 | 5 | 1.1% |
| Education | $7.89 | 1 | 0.0% |
Payments by Type
General
$324,900
447 transactions
Research
$3,500
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $201,010 | 222 | $0 (2024) |
| GlaxoSmithKline, LLC. | $59,237 | 65 | $0 (2024) |
| Greer Laboratories, Inc. | $16,626 | 19 | $0 (2017) |
| Mylan Specialty L.P. | $16,262 | 41 | $0 (2018) |
| GENZYME CORPORATION | $10,863 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $7,074 | 7 | $0 (2024) |
| AERIN MEDICAL INC. | $6,599 | 13 | $0 (2024) |
| ALK-Abello, Inc | $5,826 | 9 | $0 (2021) |
| Genentech USA, Inc. | $2,125 | 1 | $0 (2020) |
| Gyrus ACMI, Inc. | $1,294 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $72,717 | 69 | Optinose US, Inc. ($45,365) |
| 2023 | $34,196 | 50 | GlaxoSmithKline, LLC. ($17,099) |
| 2022 | $42,325 | 58 | OptiNose US, Inc. ($33,089) |
| 2021 | $51,317 | 52 | Optinose US, Inc. ($27,149) |
| 2020 | $36,070 | 42 | OptiNose US, Inc. ($28,594) |
| 2019 | $41,107 | 70 | OptiNose US, Inc. ($40,480) |
| 2018 | $12,856 | 31 | Optinose US, Inc. ($11,324) |
| 2017 | $37,812 | 80 | Greer Laboratories, Inc. ($16,626) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Optinose US, Inc. | Xhance (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $6.28 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Smith+Nephew, Inc. | — | Food and Beverage | In-kind items and services | $16.23 | General |
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $84.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | Cash or cash equivalent | $28.27 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/23/2024 | AERIN MEDICAL INC. | RHINAER STYLUS (Device) | — | Cash or cash equivalent | $1,400.00 | Research |
| Study: CTP 1450 - SOOTHE • Category: EAR NOSE & THROAT | ||||||
| 11/22/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/21/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $87.10 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $417.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $344.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $52.68 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,300.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/06/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $227.80 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/02/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | In-kind items and services | $903.45 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,400.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | AERIN MEDICAL INC. | RHINAER STYLUS (Device) | — | Cash or cash equivalent | $400.00 | Research |
| Study: CTP 1450 - SOOTHE • Category: EAR NOSE & THROAT | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/17/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/16/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CTP 1450 - SOOTHE | AERIN MEDICAL INC. | $3,500 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 943 | 1,091 | $227,135 | $73,244 |
| 2022 | 11 | 1,050 | 1,303 | $244,985 | $85,966 |
| 2021 | 12 | 1,100 | 1,302 | $235,028 | $92,707 |
| 2020 | 10 | 986 | 1,168 | $153,155 | $60,085 |
Total Patients
4,079
Total Services
4,864
Medicare Billing
$312,002
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 239 | 289 | $48,115 | $16,594 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 146 | 171 | $40,185 | $15,146 | 37.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 136 | 136 | $27,200 | $9,219 | 33.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 85 | 101 | $23,230 | $8,646 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $21,000 | $8,206 | 39.1% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 195 | 240 | $43,700 | $6,931 | 15.9% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 47 | 48 | $15,840 | $5,890 | 37.2% |
| 69433 | Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | Office | 2023 | 11 | 11 | $3,740 | $1,345 | 36.0% |
| 69220 | Simple removal of skin debris and drainage of mastoid cavity | Office | 2023 | 14 | 25 | $4,125 | $1,267 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 248 | 298 | $49,170 | $18,270 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 146 | 176 | $41,360 | $14,726 | 35.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 137 | 137 | $27,400 | $10,329 | 37.7% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 90 | 113 | $25,990 | $10,238 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $22,200 | $8,917 | 40.2% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 210 | 262 | $39,900 | $7,390 | 18.5% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 48 | 52 | $17,160 | $6,991 | 40.7% |
| 30903 | Complex control of nose bleed | Office | 2022 | 21 | 24 | $9,600 | $4,479 | 46.7% |
| 69433 | Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | Office | 2022 | 13 | 13 | $4,420 | $2,112 | 47.8% |
| 69220 | Simple removal of skin debris and drainage of mastoid cavity | Office | 2022 | 14 | 29 | $4,785 | $1,628 | 34.0% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 49 | 125 | $3,000 | $886.24 | 29.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 241 | 303 | $49,665 | $19,850 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 188 | $42,100 | $15,834 | 37.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 125 | 125 | $36,820 | $15,087 | 41.0% |
| 31575 | Diagnostic examination of voice box using flexible endoscope | Office | 2021 | 91 | 107 | $23,510 | $10,047 | 42.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 121 | 121 | $24,050 | $9,686 | 40.3% |
About Dr. Mark Mehle, MD
Dr. Mark Mehle, MD is a Otolaryngology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760574982.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Mehle, MD has received a total of $328,400 in payments from pharmaceutical and medical device companies, with $72,717 received in 2024. These payments were reported across 452 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($253,677).
As a Medicare-enrolled provider, Mehle has provided services to 4,079 Medicare beneficiaries, totaling 4,864 services with total Medicare billing of $312,002. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Otolaryngology
- Location Cleveland, OH
- Active Since 09/28/2006
- Last Updated 09/18/2023
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1760574982
Products in Payments
- Xhance (Drug) $201,010
- NUCALA (Biological) $59,078
- DUPIXENT (Biological) $17,835
- Dymista (Drug) $16,262
- Oralair (Drug) $11,926
- RHINAER STYLUS (Device) $6,300
- Grastek (Biological) $4,250
- Xolair (Biological) $2,125
- Odactra (Drug) $1,387
- PROPEL (Device) $275.03
- CIPRODEX (Drug) $171.85
- ACCLARENT AERA Eustachian Tube Balloon Dilation System (Device) $170.19
- VIVAER STYLUS (Device) $167.33
- ENTELLUS - ENTELLUS MEDICAL REINFORCED ANESTHESIA NEEDLE (Device) $127.83
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $101.19
- FASENRA (Drug) $84.05
- AUDION ET DILATION SYSTEM (Device) $81.22
- NURTEC ODT (Drug) $66.40
- Otiprio (Drug) $62.25
- LIBTAYO (Biological) $60.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Cleveland
Raj Sindwani, Md, MD
Otolaryngology — Payments: $501,907
Otolaryngology $501,907
Mr. Brian Gastman, Md, MD
Otolaryngology — Payments: $136,145
Otolaryngology $136,145
Rod Rezaee, Md, MD
Otolaryngology — Payments: $112,794
Otolaryngology $112,794
Dr. Sanjeet Rangarajan, M.d, M.D
Otolaryngology — Payments: $112,183
Otolaryngology $112,183
Alejandro Rivas Campo, M.d,, M.D,
Otolaryngology — Payments: $51,843
Otolaryngology $51,843
Dr. Sarah Mowry, Md, MD
Otolaryngology — Payments: $51,264
Otolaryngology $51,264